TRIM
ABBV icon

Thompson Rubinstein Investment Management’s AbbVie ABBV Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$6.63M Buy
82,263
+330
+0.4% +$27K 2.13% 17
2018
Q4 		$7.55M Sell
81,933
-500
-0.6% -$44K 2.78% 14
2018
Q3 		$7.8M Sell
82,433
-600
-0.7% -$56.9K 2.39% 13
2018
Q2 		$7.69M Sell
83,033
-1,124
-1% -$110K 2.57% 13
2018
Q1 		$7.96M Hold
84,157
– – 2.71% 14
2017
Q4 		$8.14M Sell
84,157
-525
-0.6% -$49.5K 2.68% 11
2017
Q3 		$7.53M Sell
84,682
-197
-0.2% -$15K 2.63% 12
2017
Q2 		$6.16M Sell
84,879
-2,025
-2% -$136K 2.27% 14
2017
Q1 		$5.66M Buy
86,904
+972
+1% +$61.1K 2.06% 17
2016
Q4 		$5.38M Buy
85,932
+5,920
+7% +$361K 1.99% 18
2016
Q3 		$5.05M Sell
80,012
-1,771
-2% -$115K 1.92% 18
2016
Q2 		$5.06M Buy
81,783
+9,543
+13% +$581K 1.97% 17
2016
Q1 		$4.13M Buy
72,240
+25,226
+54% +$1.41M 1.68% 24
2015
Q4 		$2.79M Sell
47,014
-9,817
-17% -$565K 1.28% 25
2015
Q3 		$3.09M Buy
56,831
+3,046
+6% +$198K 1.37% 28
2015
Q2 		$3.61M Sell
53,785
-774
-1% -$50.5K 1.44% 27
2015
Q1 		$3.19M Buy
54,559
+2,786
+5% +$168K 1.25% 32
2014
Q4 		$3.39M Sell
51,773
-3,401
-6% -$214K 1.3% 31
2014
Q3 		$3.19M Buy
55,174
+18,343
+50% +$1.02M 1.25% 34
2014
Q2 		$2.08M Buy
+36,831
New +$1.93M 0.78% 42

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thompson Rubinstein Investment Management's ABBV Position: Q1 2019 in Review

Thompson Rubinstein Investment Management increased its AbbVie (ABBV) stake by 0.4% in Q1 2019, buying an estimated $27K and bringing the position to 82,263 shares worth $6.63M. The position accounts for 2.13% of the portfolio, ranked #17.

Thompson Rubinstein Investment Management first reported a position in ABBV in Q2 2014 and has held it in 20 quarters since. The position peaked at $8.14M in Q4 2017. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Thompson Rubinstein Investment Management held 82,263 shares of AbbVie worth $6.63M as of Q1 2019.
  • Thompson Rubinstein Investment Management bought 330 AbbVie shares in Q1 2019, an estimated $27K.
  • AbbVie made up 2.13% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #17 holding.
  • Thompson Rubinstein Investment Management first reported a position in AbbVie in Q2 2014 and has held it in 20 quarters since.
  • Thompson Rubinstein Investment Management's AbbVie position peaked at $8.14M in Q4 2017.
  • 2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.